Mynvax

Mynvax is a clinical-stage vaccine biotechnology company based in Bengaluru, India, developing recombinant, thermostable vaccines for respiratory viral infections. Spun out of the Indian Institute of Science (IISc), the company applies protein-stabilization and structure-based antigen design to create thermotolerant COVID-19 and influenza vaccine candidates aimed at affordable distribution in low- and lower-middle-income countries without deep cold-chain requirements. Mynvax is a life-sciences research company and does not currently publish a public developer API, documentation portal, or technical integration surface. This profile was surfaced as a portfolio company of Accel and is maintained in the API Evangelist network for discovery.

Mynvax is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Vaccines, and Life Sciences.

Mynvax’s developer surface includes product news and 1 more developer resources.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealthcareBiotechnologyVaccinesLife SciencesPharmaceuticalsResearch

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/mynvax: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 2

The organization behind the API

Website

Website

News

News

Source (apis.yml)

aid: mynvax
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/mynvax.png
name: Mynvax
description: Mynvax is a clinical-stage vaccine biotechnology company based in Bengaluru, India, developing recombinant, thermostable
  vaccines for respiratory viral infections. Spun out of the Indian Institute of Science (IISc), the company applies protein-stabilization
  and structure-based antigen design to create thermotolerant COVID-19 and influenza vaccine candidates aimed at affordable
  distribution in low- and lower-middle-income countries without deep cold-chain requirements. Mynvax is a life-sciences research
  company and does not currently publish a public developer API, documentation portal, or technical integration surface. This
  profile was surfaced as a portfolio company of Accel and is maintained in the API Evangelist network for discovery.
url: https://raw.githubusercontent.com/api-evangelist/mynvax/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- accel
x-tier: stub
x-tier-reason: portfolio-lead
x-website: https://mynvax.com
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Healthcare
- Biotechnology
- Vaccines
- Life Sciences
- Pharmaceuticals
- Research
apis: []
common:
- type: Website
  url: https://mynvax.com
- type: News
  url: https://mynvax.com/news.html
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1